Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05657990 · ClinicalTrials.gov registry record · Early Phase 1

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

A Early Phase 1 study of Urinary Retention, sponsored by Hackensack Meridian Health.

Recruiting
Registry status
Early Phase 1
Development phase
46
Enrollment target
4
Study locations

NCT05657990 is a Early Phase 1 study of Urinary Retention that is actively recruiting participants, run by Hackensack Meridian Health. The registered enrollment target is 46 participants, below the 136-participant average among 11 other Urinary Retention trials with a reported enrollment target (66% lower). The trial reports 4 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05657990, a Early Phase 1 study of Urinary Retention, is actively recruiting participants, sponsored by Hackensack Meridian Health.

RECRUITING
Registry status
Early Phase 1
Development phase
46 participants
Enrollment target
4
Study locations

Study Summary

This is a feasibility study looking at whether the use of Tamsulosin could lower the high incidence of postoperative urinary retention (POUR) in older men who undergo an oncological thoracic surgical procedure for suspected or confirmed cancer. In addition, the study will try to identify the time of resumption of presurgical urinary function post Tamsulosin administration.

Conditions Studied

Interventions

  • DRUG Tamsulosin

Study Locations (4)

New Jersey

  • Ocean University Medical Center - Brick
  • South Ocean University Medical Center - Manahawkin
  • Jersey Shore University Medical Center - Neptune City
  • Riverview Medical Center - Red Bank

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2023-04-03
Est. Completion 2026-12
Phase Early Phase 1

Sponsor

Hackensack Meridian Health

90 total trials

What the Registry Record Tells You About NCT05657990

The ClinicalTrials.gov registry entry for NCT05657990 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 136-participant average among 11 other Urinary Retention trials with a reported enrollment target (66% lower). The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Urinary Retention appearing as the primary indexed condition, and to 1 intervention - of which Tamsulosin is the first listed.

NCT05657990 reports 4 study locations spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT05657990 about?

NCT05657990 is a clinical study titled "Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery". This is a feasibility study looking at whether the use of Tamsulosin could lower the high incidence of postoperative urinary retention (POUR) in older men who undergo an oncological thoracic surgical procedure for suspected or confirmed cancer. In addition, the study will try to identify the time of...

What is the current status of trial NCT05657990?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 46 participants. The study started on 2023-04-03. Estimated completion is 2026-12.

What conditions does trial NCT05657990 study?

This clinical trial studies the following conditions: Urinary Retention.

What interventions are being tested in trial NCT05657990?

The interventions under investigation include: Tamsulosin (DRUG).

Who is sponsoring clinical trial NCT05657990?

This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05657990 being conducted?

This trial has 4 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Urinary Retention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.